D

Daan Gene Co Ltd
SZSE:002030

Watchlist Manager
Daan Gene Co Ltd
SZSE:002030
Watchlist
Price: 6.22 CNY 0.97% Market Closed
Market Cap: 8.7B CNY

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Daan Gene Co Ltd

Revenue
765.5m CNY
Cost of Revenue
-525.8m CNY
Gross Profit
239.7m CNY
Operating Expenses
-983.7m CNY
Operating Income
-744m CNY
Other Expenses
180m CNY
Net Income
-564m CNY

Margins Comparison
Daan Gene Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Daan Gene Co Ltd
SZSE:002030
8.7B CNY
31%
-97%
-74%
IL
Can Fite Biopharma Ltd
TASE:CANF
707T ILS
0%
-1 487%
-1 456%
FR
Pharnext SCA
OTC:PNEXF
6T USD
0%
-17 527%
-21 040%
US
Abbvie Inc
NYSE:ABBV
404.7B USD
71%
33%
4%
US
Amgen Inc
NASDAQ:AMGN
181.6B USD
72%
34%
19%
US
Gilead Sciences Inc
NASDAQ:GILD
153.6B USD
79%
39%
28%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.2B USD
86%
39%
31%
US
Epizyme Inc
F:EPE
94.1B EUR
76%
-370%
-392%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
85B USD
86%
28%
32%
AU
CSL Ltd
ASX:CSL
84.5B AUD
52%
26%
19%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
55.2B USD
84%
8%
1%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Daan Gene Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Daan Gene Co Ltd
SZSE:002030
8.7B CNY
-7%
-6%
-9%
-8%
IL
Can Fite Biopharma Ltd
TASE:CANF
707T ILS
-383%
-187%
-273%
-6 189%
FR
Pharnext SCA
OTC:PNEXF
6T USD
115%
-391%
275%
3 093%
US
Abbvie Inc
NYSE:ABBV
404.7B USD
139%
2%
20%
28%
US
Amgen Inc
NASDAQ:AMGN
181.6B USD
82%
8%
17%
15%
US
Gilead Sciences Inc
NASDAQ:GILD
153.6B USD
41%
14%
25%
19%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.2B USD
22%
16%
23%
25%
US
Epizyme Inc
F:EPE
94.1B EUR
-877%
-67%
-73%
-182%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
85B USD
15%
12%
11%
12%
AU
CSL Ltd
ASX:CSL
84.5B AUD
16%
8%
12%
10%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
55.2B USD
33%
1%
8%
-21%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less